Shares of Celsius Holdings surged after the company said it would buy rival energy-drink maker Alani Nu for $1.8 billion, and it logged higher-than-expected profit and revenue in the fourth quarter.

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...

CNS Pharmaceuticals (CNSP) announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company’s common stock ...

Occidental Petroleum disappointed shareholders with acquisitions reducing shareholder returns. Read why OXY bonds with about ...

This has some investors continuing to worry that the stock market in general might be overvalued. But there are always stocks that are cheaply priced. Below is a screen of stocks trading well ...

NextNRG (EZFL) has announced the pricing of a public offering of 5 million shares of its common stock at $3.00 per share, for gross proceeds of approximately $15 million.

Detailed price information for Evokai Creative Labs Inc (OKAI-X) from The Globe and Mail including charting and trades.

Nvidia stock ranked among the top Google searches of 2024, driven by its innovations in AI, graphics processing, and semiconductors. Nvidia’s technological advancements have made it a key player ...

Nvidia stock (NVDA) clawed back some losses Tuesday after Monday's DeepSeek-fueled 17% crash. At the end of the trading day, Nvidia stock stood 8.9% higher at $128.99. The move helped stoke a ...

Televisions broadcast stock market information outside the Nasdaq MarketSite in New York on Monday, Jan. 27, 2025. [Photo: Yuki Iwamura/Bloomberg via Getty Images] Yesterday, shockwaves rippled ...

Investors around the world are reassessing the prospects for technology companies after a Chinese artificial intelligence start-up rocked markets in the United States on Monday. By Joe Rennison ...

Susan Dziubinski: Hi. I’m Susan Dziubinski with Morningstar. Growth stocks looked about 24% overvalued coming into 2025, according to Morningstar. But that doesn’t mean that all growth stocks ...